(Total Views: 939)
Posted On: 03/06/2023 11:41:00 PM
Post# of 148870
"AAV-delivered Leronlimab for functional HIV cure?"
Don't think this link has been posted -- it originates from Sacha Lab (via Jonah Sacha who as most of you know, is on Cytodyn's Scientific Advisory Board):
http://presentations.hiv-persistence.com/2022...3-Webb.pdf
Jonah B. Sacha, PhD
Dr. Sacha graduated cum laude from the University of Missouri-Columbia in 2003 with a B.A. in German and B.S. in Biology. After receiving his Ph.D. in Medical Microbiology & Immunology from the University of Wisconsin-Madison in 2007, he joined the faculty at UW-Madison, where he researched the characteristics of effective retrovirus-specific CD8+ and CD4+ T cells. In 2011, he joined the Oregon Health & Science University and has appointments in both the Vaccine & Gene Therapy Institute and Oregon National Primate Research Center.
Dr. Sacha will lead CytoDyn’s team efforts in HIV PreP and HIV cure.
Don't think this link has been posted -- it originates from Sacha Lab (via Jonah Sacha who as most of you know, is on Cytodyn's Scientific Advisory Board):
http://presentations.hiv-persistence.com/2022...3-Webb.pdf
Jonah B. Sacha, PhD
Dr. Sacha graduated cum laude from the University of Missouri-Columbia in 2003 with a B.A. in German and B.S. in Biology. After receiving his Ph.D. in Medical Microbiology & Immunology from the University of Wisconsin-Madison in 2007, he joined the faculty at UW-Madison, where he researched the characteristics of effective retrovirus-specific CD8+ and CD4+ T cells. In 2011, he joined the Oregon Health & Science University and has appointments in both the Vaccine & Gene Therapy Institute and Oregon National Primate Research Center.
Dr. Sacha will lead CytoDyn’s team efforts in HIV PreP and HIV cure.
(11)
(0)Scroll down for more posts ▼
